Chembio Diagnostics Inc - ESG Rating & Company Profile powered by AI
This webpage contains a free Sustainability analysis for Chembio Diagnostics Inc. The ESG score for Chembio Diagnostics Inc indicates the company's reporting of the United Nations SDGs. Other corporations in the rating industry group for Chembio Diagnostics Inc are displayedin the table.
Chembio Diagnostics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.4; made up of an environmental score of 2.7, social score of 1.6 and governance score of 0.0.
1.4
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1715 | Polaris Group | 1.6 | Low |
1715 | RenovaCare Inc | 1.6 | Low |
1747 | Chembio Diagnostics Inc | 1.4 | Low |
1747 | Pharmaron Beijing Co Ltd | 1.4 | Low |
1747 | Genscript Biotech Corp | 1.4 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Chembio Diagnostics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Chembio Diagnostics Inc disclose current and historical energy intensity?
Does Chembio Diagnostics Inc report the average age of the workforce?
Does Chembio Diagnostics Inc reference operational or capital allocation in relation to climate change?
Does Chembio Diagnostics Inc disclose its ethnicity pay gap?
Does Chembio Diagnostics Inc disclose cybersecurity risks?
Does Chembio Diagnostics Inc offer flexible work?
Does Chembio Diagnostics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Chembio Diagnostics Inc disclose the number of employees in R&D functions?
Does Chembio Diagnostics Inc conduct supply chain audits?
Does Chembio Diagnostics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Chembio Diagnostics Inc conduct 360 degree staff reviews?
Does Chembio Diagnostics Inc disclose the individual responsible for D&I?
Does Chembio Diagnostics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Chembio Diagnostics Inc disclose current and / or historical scope 2 emissions?
Does Chembio Diagnostics Inc disclose water use targets?
Does Chembio Diagnostics Inc have careers partnerships with academic institutions?
Did Chembio Diagnostics Inc have a product recall in the last two years?
Does Chembio Diagnostics Inc disclose incidents of discrimination?
Does Chembio Diagnostics Inc allow for Work Councils/Collective Agreements to be formed?
Has Chembio Diagnostics Inc issued a profit warning in the past 24 months?
Does Chembio Diagnostics Inc disclose parental leave metrics?
Does Chembio Diagnostics Inc disclose climate scenario or pathway analysis?
Does Chembio Diagnostics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Chembio Diagnostics Inc disclose the pay ratio of women to men?
Does Chembio Diagnostics Inc support suppliers with sustainability related research and development?
Does Chembio Diagnostics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Chembio Diagnostics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Chembio Diagnostics Inc involved in embryonic stem cell research?
Does Chembio Diagnostics Inc disclose GHG and Air Emissions intensity?
Does Chembio Diagnostics Inc disclose its waste policy?
Does Chembio Diagnostics Inc report according to TCFD requirements?
Does Chembio Diagnostics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Chembio Diagnostics Inc disclose energy use targets?
Does Chembio Diagnostics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Chembio Diagnostics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Chembio Diagnostics Inc
These potential risks are based on the size, segment and geographies of the company.
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.